Table 5_Exploring the celecoxib–cervical cancer relationship using in vitro, network pharm

16.6 KB Excel file from a 2026 figshare upload by Tongfei Wang. The dataset likely contains results from a multi-method study investigating the anticancer role of celecoxib. The research combined in vitro assays, network pharmacology, and Mendelian randomization analyses to explore immune-related mechanisms.

Use Cases

• Validate drug efficacy hypotheses based on in vitro assay results likely contained in the data.
• Explore causal relationships between drug targets and disease risk based on Mendelian randomization results.
• Analyze immune pathway associations based on network pharmacology and enrichment analysis findings.
• Replicate statistical analyses of mediation effects based on reported percentages like the 28.458% mediation effect.

Strengths

• Data integrates results from three distinct methodological approaches: in vitro experiments, network pharmacology, and Mendelian randomization.
• Specific statistical results are reported, such as an odds ratio of 0.736 for genetically proxied NEU1 inhibition.
• The dataset is openly licensed under CC-BY-4.0.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (16.6 KB), indicating limited scope or summary-level data.

Provenance

Source

Tongfei Wang via figshare.

Collection Method

Likely contains synthesized results from Cell Counting Kit-8, wound-healing, colony-formation, transwell assays, network pharmacology, enrichment analyses, and Mendelian randomization.

Freshness

Last updated 2026-05-19 05:41:47; freshness should be verified.